Fng Liquid
NDC Package 43857-0424-1
Package Information
Fng (echinacea (angustifolia), lomatium dissectum, nasturtium aquaticum, tabebuia impetiginosa, hydrastis canadensis, iodium, adrenalinum, argentum metallicum, thymus (suis), thyroidinum (suis), phosphoricum acidum, candida albicans, lycopodium clavatum, pulsatilla (vulgaris), sepia) liquids is for temporary relief of bloating of the stomach, flatulence, and allergic rhinitis. This formulation utilizes a liquid delivery system. Marketed by Bioactive Nutritional, Inc., this product is identified by NDC 43857-0424.
Identification & Billing
Clinical Specifications
- ECHINACEA ANGUSTIFOLIA WHOLE 12 [hp_X]/mL
- LOMATIUM DISSECTUM ROOT 3 [hp_X]/mL
- NASTURTIUM OFFICINALE 8 [hp_X]/mL
- TABEBUIA IMPETIGINOSA BARK 5 [hp_X]/mL
- GOLDENSEAL 6 [hp_X]/mL
- IODINE 3 [hp_X]/mL
- EPINEPHRINE 30 [hp_X]/mL
- SILVER 3 [hp_X]/mL
- SUS SCROFA THYMUS 12 [hp_X]/mL
- THYROID 30 [hp_X]/mL
- PHOSPHORIC ACID 30 [hp_X]/mL
- CANDIDA ALBICANS 8 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 8 [hp_X]/mL
- PULSATILLA VULGARIS WHOLE 3 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 8 [hp_X]/mL
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Fungal Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Fungal Allergenic Extract - [EPC] (Established Pharmacologic Class)
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 43857 - Bioactive Nutritional, Inc.
- 43857-0424 - Fng
- 43857-0424-1 - 30 mL in 1 BOTTLE, DROPPER
- 43857-0424 - Fng
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43857-0424-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Fng II, a human over the counter drug labeled by Bioactive Nutritional, Inc.. This liquid is formulated for oral use and contains echinacea angustifolia whole; lomatium dissectum root; nasturtium officinale; tabebuia impetiginosa bark; goldenseal; iodine; epinephrine; silver; sus scrofa thymus; thyroid; phosphoric acid; candida albicans; lycopodium clavatum spore; pulsatilla vulgaris whole; sepia officinalis juice as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bioactive Nutritional, Inc. on December 20, 2016. The current certification is valid through December 31, 2027.
How is this Bioactive Nutritional, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43857042401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.